Literature DB >> 10077138

The pathogenesis of osteonecrosis and the relationships to corticosteroids.

R Mirzai1, C Chang, A Greenspan, M E Gershwin.   

Abstract

One of the challenging issues faced by allergists is a risk-benefit analysis on the use of corticosteroids. An uncommon, but serious complication of corticosteroids is the development of avascular necrosis (osteonecrosis). In this review we present the differential diagnosis and pathophysiology of osteonecrosis, with particular emphasis on steroids. Osteonecrosis of the femoral head is a common disorder that may be either naturally occurring or iatrogenic. With the exception of those cases labeled as idiopathic, the majority are the result of some insult to the vascular integrity of the affected hip. The reason for this disruption is manifold and can range from direct trauma to the more subtle or indirect compromise associated with fatty emboli or often an intravascular event such as that seen in sickle cell anemia. Although they are not totally understood, corticosteroids present a special problem because of susceptibility factors that may make some patients more likely to get osteonecrosis than others. The problem may be more complex, in that the association between corticosteroid use and osteonecrosis may be disease-dependent. In any case, any patient receiving long-term corticosteroids should be warned of this potentially debilitating complication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077138     DOI: 10.3109/02770909909065152

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  11 in total

1.  Avascular necrosis in HIV.

Authors:  Puja Mehta; Mark Nelson; Alexander Brand; Fiona Boag
Journal:  Rheumatol Int       Date:  2011-09-22       Impact factor: 2.631

2.  Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.

Authors:  Jason Fangusaro; Sridharan Gururangan; Regina I Jakacki; Sue C Kaste; Stewart Goldman; Ian F Pollack; James M Boyett; Larry E Kun
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

Review 3.  Cluster headache.

Authors:  Manjit Matharu
Journal:  BMJ Clin Evid       Date:  2010-02-09

4.  Risk factors and pathogenesis of steroid-induced osteonecrosis of femoral head - A scoping review.

Authors:  Vikas Birla; Abhishek Vaish; Raju Vaishya
Journal:  J Clin Orthop Trauma       Date:  2021-10-13

Review 5.  Management of trigeminal autonomic cephalgias and hemicrania continua.

Authors:  Manjit S Matharu; Christopher J Boes; Peter J Goadsby
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Cluster headache pathophysiology - insights from current and emerging treatments.

Authors:  Diana Y Wei; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2021-03-29       Impact factor: 42.937

7.  Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.

Authors:  Marcin Kos
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

8.  Avascular necrosis as a part of 'long COVID-19'.

Authors:  Sanjay R Agarwala; Mayank Vijayvargiya; Prashant Pandey
Journal:  BMJ Case Rep       Date:  2021-07-02

9.  Association of dental and periodontal status with bisphosphonate-related osteonecrosis of the jaws. A retrospective case controlled study.

Authors:  Marcin Kos
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

10.  Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ.

Authors:  Daigo Yoshiga; Ikuo Nakamichi; Yoshihiro Yamashita; Noriaki Yamamoto; Kensuke Yamauchi; Shinnosuke Nogami; Takeshi Kaneuji; Sho Mitsugi; Kenkou Tanaka; Yoshihiro Kataoka; Takuma Sakurai; Hiroyasu Kiyomiya; Ikuya Miyamoto; Tetsu Takahashi
Journal:  J Clin Exp Dent       Date:  2014-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.